REFERENCES
- Butler A. A., Blakesley V. A., Poulaki V., Tsokos M., Wood T. L., et al. Stimulation of tumor growth by recombinant human insulin-like growth factor 1 (IGF-1) is dependent on the dose and the level of IGF-1 receptor expression[published erratum appears in Cancer Res., 1998, 58, 5630]. Cancer Res. 1998; 58: 3021–3027
- Claire E., Stewad H. O. U. R., Rotwein P. Growth, differention and survival: multipul physiological function for Insulin-like growth factors. Physiol. Rew. 1996; 76: 1005–1026
- Freier S., Weiss O., Eran M., Flyvbjerg A., Dahan R., et al. Expression of the Insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 1999; 44: 704–708
- Seep-Lorenzino L. Structure and function of the insulin-like growth factor 1 receptor. Breast Cancer Res. 1998; 47: 235–253
- Adams T. E., Epa V. C., Gavrett T. P., et al. Structure and function of the type I insulin-like growth factor receptor. Cell Mol. Life Sci. 2000; 57(7)1050–1093
- Szepeshazi K., Schally A. V., Groot K., Armatis P., Halmos G., et al. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers. Br. J. Cancer 2000; 82: 1724–1731
- Flossmann-Kast B. B., Jehle P. M., Hoeflich A., Adler G., Lutz M. P. Src stimulates Insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-IReceptor number in human pancreatic carcinoma cells. Cancer Res. 1998; 58: 3551–3554
- Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell Physiol. 2000; 183(1)1–9
- Baserga R., Resnicoff M., Dews M. The IGF-1 receptor and cancer. Endocrine 1997; 7: 99–102
- Baserga R., Hongo A., Rubini M., Prisco M., Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1997; 1332: F105–F126
- Werner H. O. U. R., Le Roith D. The insulin-like growth factor-1 receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit. Rev. Oncog 1997; 8: 71–92
- Hakam A., Yeatman T. J., Lu L., Mora L., Marce G., Nicosia S. V., et al. Expression of insulin-like growth factor 1 receptor in human colorectal cancer. Hum. Pathol. 1999; 30: 1128–1133
- Chi M. M., Schlein A. L., Moley K. H. High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via downregulation of the IGF-1 receptor. Endocrinology 2000; 141: 4787–4792
- Anodrew L., Kung S., Anders Z., et al. Cytotoxic effects of cell phase specific angents : result of cell cycle perturbation. Cancer Res. 1999; 50(4)7307
- Nakamura K., Hongo A., Kodama J., Miyagi Y., Yoshinouchi M., Kudo T. Down-regulation of the insulin-like growth factor 1 receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res. 2000; 60: 760–765
- Hailey J., Maxwell E., Koukouras K., et al. Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells. Mol. Cancer Therapeu. 2002; 7: 1347–1353
- Reinmuth N., Liu W., Fan F., et al. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clin. Cancer Res. 2002; 8: 3259–3269
- O'Connor R., Kauffmann-Zeh A., Liu Y., Lehar S., Evan G. I., Baserga R., Blattler W. A. Identification of domains of the insulin-like growth factor 1 receptor that are reguired for protection from apoptosis. Mol. Cell. Biol 1997; 17: 427–435
- Romano G., Prisco M., Zanocco-Marani T., Peruzzi F., Valentinis B., Baserga R. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-1 receptor signaling. J. Cell. Biochem 1999; 72: 294–310